Momester Nasal (Mometasone Furoate)

Mometasone furoate binds to glucocorticoid receptors in nasal mucosal cells, altering gene transcription to suppress inflammatory cytokines, reducing edema and immune cell infiltration, thereby decreasing nasal inflammation.

The specific dosing regimen is determined by the prescribing clinician based on the patient’s age, severity of symptoms and clinical guidelines; patients should follow the instructions on the prescription label.

Safety data are limited; the product is classified as pregnancy category unknown. It should only be used if the potential benefit justifies the potential risk, and breastfeeding mothers should consult their physician.

Submit an enquiry on the product page at gnhindia.com, providing the required quantity and institutional credentials. GNH India’s sales team will verify eligibility, then respond with pricing, availability, shipping details and any necessary import documentation.

Momester Nasal contains mometasone furoate, a high‑potency glucocorticoid with low systemic bioavailability, offering similar efficacy to other intranasal steroids such as fluticasone or budesonide, but with a once‑daily dosing schedule that may improve adherence.

Keep the spray at room temperature, away from excessive heat or moisture. Store in the original packaging, protect from direct sunlight, and keep the cap tightly closed when not in use to maintain potency.

The patient tilts the head slightly forward, inserts the nozzle into one nostril, and sprays the prescribed number of sprays while breathing in gently. The process is repeated in the other nostril if directed, and the device is cleaned regularly according to the label.

Although rare, serious adverse events can include adrenal suppression, cataracts or glaucoma, and opportunistic fungal infections of the nasal mucosa. Patients should report persistent nosebleeds, visual changes, or signs of infection promptly.

Individuals with known hypersensitivity to mometasone furoate or any component of the formulation, patients with active untreated nasal infections, and those receiving systemic corticosteroids without medical supervision should avoid using this product unless directed by a physician.